| 0.9913 0.021 (2.2%) | 09-25 14:55 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 1.33  |
1-year : | 1.57 |
| Resists | First : | 1.13 |
Second : | 1.35 |
| Pivot price | 0.96 |
|||
| Supports | First : | 0.8 | Second : | 0.66 |
| MAs | MA(5) : | 0.97 |
MA(20) : | 1 |
| MA(100) : | 1.43 |
MA(250) : | 2.03 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 54 |
D(3) : | 49 |
| RSI | RSI(14): 48.9 |
|||
| 52-week | High : | 6.25 | Low : | 0.62 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CELZ ] has closed below upper band by 38.0%. Bollinger Bands are 49.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.99 - 1 | 1 - 1 |
| Low: | 0.91 - 0.91 | 0.91 - 0.92 |
| Close: | 0.96 - 0.97 | 0.97 - 0.98 |
Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.
Fri, 18 Sep 2026
Creative Medical Technology Holdings Stock Price Forecast. Should You Buy CELZ? - StockInvest.us
Thu, 17 Sep 2026
About 93% improved in a knee study. Creative Medical files a patent application. - Stock Titan
Fri, 11 Sep 2026
Creative Medical Technology Holdings Inc. (CELZ) Key Financial Ratios – Valuation, Profitability & More - Value Research
Thu, 06 Aug 2026
CELZ Stock Whipsaws As Traders Focus On Cash And Charts - StocksToTrade
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 7 (M) |
| Held by Insiders | 6.56e+006 (%) |
| Held by Institutions | 0.5 (%) |
| Shares Short | 76 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -6.13e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -208 % |
| Return on Assets (ttm) | 4.3 % |
| Return on Equity (ttm) | -47.4 % |
| Qtrly Rev. Growth | 3000 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | -38.18 |
| EBITDA (p.s.) | 985.29 |
| Qtrly Earnings Growth | -2.1 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.03 |
| Price to Cash Flow | 1.53 |
| Dividend | 0 |
| Forward Dividend | 584610 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|